Does modern radiological imaging detect lesions associated with internuclear ophthalmoplegia?
30 January 2025
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective case review including all patients with a diagnosis of internuclear ophthalmoplegia (INO) presenting to two tertiary neuro-ophthalmology centres over a five-year period. The aim of the study was to assess the sensitivity of modern radiological...
What are the characteristics of patients reporting diplopia in giant cell arteritis?
4 December 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective study of individuals diagnosed with giant cell arteritis (GCA) consecutively over a six-year period at a single tertiary ophthalmic centre. The characteristics of binocular diplopia prior to GCA diagnosis was collected from medical records and...
Comparing retinal thickness in Parkinson’s disease, essential tremor and healthy controls
4 December 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
This study aimed to compare retinal findings in chronic essential tremor (ET), early Parkinson’s disease (PD) and healthy controls. Those recruited with ET had to have received a diagnosis a minimum of three years previous and those with PD had...
Predicting outcome for visual acuity in optic neuritis associated with multiple sclerosis
3 October 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective cohort study to evaluate key predictors of long-term high-contrast visual acuity following optic neuritis associated with multiple sclerosis. All patients coded as optic neuropathy and assessed by a neuro-ophthalmologist over a 10-year period were screened...
Acromegaly associated with enlargement of extraocular recti muscles
3 October 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
This retrospective case review aimed to evaluate the frequency and extent of extraocular muscle enlargement in cases of acromegaly at presentation. All new presentations of acromegaly diagnosis at a single tertiary centre over a five-year period were screened for inclusion....
Could idebenone by the solution for treating dominant optic atrophy?
3 September 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Dominant optic atrophy (DOA) is a disease of the retinal ganglion cells, with no current treatment options. In most cases, DOA is caused by a mutation in the OPA1 gene. The aim of this study was to evaluate the effect...
Longitudinal findings in children with neurofibromatosis type 1
3 September 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
This retrospective chart review evaluates the ophthalmologic findings of children with neurofibromatosis type 1 (NF1). Optic pathway gliomas (OPGs) are the most common tumours found in children with NF1. Findings are compared between eyes with and without optic pathway gliomas...
Portable vision reading device shows promise for low vision after brain injury
2 August 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
The authors report a small sample cohort study evaluating the impact of a portable vision reading device (OrCam Read) on vision-related quality-of-life and independent functional status in patients with low vision due to stroke or brain tumours. Six patients with...
Septo-optic dysplasia – a case note review
2 August 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Septo-optic dysplasia (SOD) is a congenital disorder belonging to the midline brain malformation group. The condition manifests as a classical triad, including optic nerve hypoplasia (ONH), agenesis of midline structures (absent septum pel-lucidum and agenesis of the corpus callosum), and...
Characteristics of neuro-ophthalmic visual disturbances post-cataract surgery
2 August 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective case review of adult patients seen by neuro-ophthalmology over a nine-year period. The aim of the study was to identify the cause of neuro-ophthalmic referrals within six months of cataract surgery. Individuals already known to...
Tumour characteristics influencing visual field outcomes
2 August 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
This retrospective study aimed to explore correlations between pituitary tumour characteristics which influenced visual field changes. Cases of transsphenoidal surgery from a six-year period resulting in a pathologic diagnosis of pituitary adenoma from a single centre were identified. Individuals were...
Anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis: a retrospective medical records review
1 August 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Optic neuritis causes acute loss of visual function and can result in devastating visual dysfunction. Recently, measurements of anti-aquaporin 4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies have become available, making it possible to evaluate the disease pathogenesis. This paper...
